Relapsing Chronic Myelogenous Leukemia

specific

A finding of chronic myelogenous leukemia, BCR-ABL1 positive that is not growing and responds to treatment.

24

Centers

0

Active Trials

Cancer Funding

Top Centers for Relapsing Chronic Myelogenous Leukemia(24)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
52.1
2
NCI Comprehensive
52.1
3
NCI Comprehensive
52.1
452.1
5
NCI Comprehensive
52.1
652.1
7
NCI Comprehensive
52.1
8
NCI Comprehensive
52.1
952.1
10
NCI Comprehensive
52.1
11
NCI Comprehensive
52.1
12
NCI Comprehensive
52.1
13
NCI Comprehensive
52.1
1452.1
1552.1
1652.1
1752.1
1852.1
1952.1
2052.1
2152.1
2252.1
2352.1
2452.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →